Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi

Emerging Infectious Diseases
Stephen B GordonSteve M Graham

Abstract

Streptococcus pneumoniae infections can be prevented by using new conjugate vaccines, but these vaccines have limited serogroup coverage. We report the first serogrouping data from carried and invasive isolates obtained from children and adults in Malawi. The 7-valent vaccine would cover 41% of invasive isolates from children and 25% from adults. A 9-valent vaccine, including types 1 and 5, would cover 66% of invasive isolates from children and 55% from adults.

References

Feb 16, 1980·Lancet·B M GreenwoodI D Mar
Aug 1, 1993·Journal of Clinical Microbiology·U B Sørensen
Dec 24, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H H Crewe-BrownK P Klugman
Dec 30, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A ScottK Marsh
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S B GordonR C Read
Oct 24, 2002·The Pediatric Infectious Disease Journal·Cynthia G Whitney, Larry K Pickering

❮ Previous
Next ❯

Citations

Mar 5, 2010·The New England Journal of Medicine·Neil FrenchCharles F Gilks
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carrie L ByingtonAndrew T Pavia
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Seydou YaroBradford D Gessner
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roger EaganStephen B Gordon
Jan 28, 2014·PloS One·Effua UsufAndrew Hall
Jul 14, 2011·Emerging Infectious Diseases·Jennifer E CornickChristopher M Parry
Aug 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Calman A MacLennan, Allan Saul
Jul 26, 2011·Trends in Microbiology·Daniela M FerreiraStephen B Gordon
May 9, 2009·The Journal of Allergy and Clinical Immunology·Jerry C H TamStephen B Gordon
Dec 17, 2008·Vaccine·Hakan Erdem, Burcin Sener
Jun 13, 2013·Seminars in Immunology·Calman A MacLennan
May 17, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chrispin ChaguzaStephen D Bentley
May 29, 2004·Current Opinion in Infectious Diseases·Klara M Posfay-Barbe, Ellen R Wald
Feb 20, 2004·The Cochrane Database of Systematic Reviews·E G DaviesN Dower
Jan 10, 2019·Transactions of the Royal Society of Tropical Medicine and Hygiene·Holly C SmithJamie Rylance
May 22, 2018·Computational and Mathematical Methods in Medicine·Joshua Kiddy K AsamoahHemen Dutta
Jan 24, 2019·Wellcome Open Research·Stephen B GordonUNKNOWN Malawi Research Ethics Workshop 2018 Participants

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
William P HausdorffG R Siber
The Pediatric Infectious Disease Journal
James D CampbellMyron Levine
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Sandra S RichterGary V Doern
© 2022 Meta ULC. All rights reserved